CFDE Data Portal | Search NDUFS3

	Label	Description
	NDUFS3 associations Collection (Entity type)	Associations for NDUFS3_associations
	NDUFS3 Down Gene Set (Entity type)	A Gene Set from LINCS
	NDUFS3 Up Gene Set (Entity type)	A Gene Set from LINCS
	NDUFS3 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	NDUFS3 Gene (Entity type)	ENSG00000213619 - NADH:ubiquinone oxidoreductase core subunit S3
	NDUFS3 Gene (Entity type)	ENSG00000285387 - NADH:ubiquinone oxidoreductase core subunit S3 [Source:HGNC Symbol;Acc:HGNC:7710]
	GSE166914 1 V 2 ABEMACICLIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 10 v 15 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE196035 GSE196037 MEN1 inhibition 5 v 11 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE163862 2 V 3 CISPLATIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS

NDUFS3 associations

Associations for NDUFS3_associations

NDUFS3 Down

A Gene Set from LINCS

NDUFS3 Up

A Gene Set from LINCS

NDUFS3 associations.tsv

A file from IDG as part of the Harmonizome project

NDUFS3

ENSG00000213619 - NADH:ubiquinone oxidoreductase core subunit S3

NDUFS3

ENSG00000285387 - NADH:ubiquinone oxidoreductase core subunit S3 [Source:HGNC Symbol;Acc:HGNC:7710]

GSE166914 1 V 2 ABEMACICLIB HUMAN DN

A Gene Set from LINCS

GSE252944 AKT inhibition 10 v 15 human dn

A Gene Set from LINCS

GSE196035 GSE196037 MEN1 inhibition 5 v 11 human dn

A Gene Set from LINCS

GSE163862 2 V 3 CISPLATIN MOUSE DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.